BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 16376442)

  • 1. Soluble CD40 ligand and interleukin-6 in the coronary circulation after acute myocardial infarction.
    Ohashi Y; Kawashima S; Mori T; Terashima M; Ichikawa S; Ejiri J; Awano K
    Int J Cardiol; 2006 Sep; 112(1):52-8. PubMed ID: 16376442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory and vasoactive factors in the aspirate from the culprit coronary artery of patients with acute myocardial infarction.
    Ko YG; Jung JH; Park S; Choi E; Joung B; Hwang KC; Ha JW; Choi D; Jang Y; Chung N; Shim WH; Cho SY
    Int J Cardiol; 2006 Sep; 112(1):66-71. PubMed ID: 16309761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between upregulation of CD40 system and complex stenosis morphology in patients with acute coronary syndrome.
    Yan JC; Wu ZG; Kong XT; Zong RQ; Zhan LZ
    Acta Pharmacol Sin; 2004 Feb; 25(2):251-6. PubMed ID: 14769218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased levels of interleukin-6 and matrix metalloproteinase-9 are of cardiac origin in acute coronary syndrome.
    Shu J; Ren N; Du JB; Zhang M; Cong HL; Huang TG
    Scand Cardiovasc J; 2007 Jun; 41(3):149-54. PubMed ID: 17487763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial endothelin-1 release and indices of inflammation during angioplasty for acute myocardial infarction and stable coronary artery disease.
    Taylor AJ; Bobik A; Richards M; Kaye D; Raines G; Gould P; Jennings G
    Am Heart J; 2004 Aug; 148(2):e10. PubMed ID: 15309013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between cytokines and sCD40L in patients with stable and unstable coronary syndromes.
    Tousoulis D; Antoniades C; Nikolopoulou A; Koniari K; Vasiliadou C; Marinou K; Koumallos N; Papageorgiou N; Stefanadi E; Siasos G; Stefanadis C
    Eur J Clin Invest; 2007 Aug; 37(8):623-8. PubMed ID: 17635572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes and relations of soluble plasma CD40L and matrix metalloproteinase-9 levels in patients with coronary heart disease].
    Li J; Zhao SP; Peng DQ; Zhou HN
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 29(5):517-20. PubMed ID: 16137036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced cardiac production of matrix metalloproteinase-2 and -9 and its attenuation associated with pravastatin treatment in patients with acute myocardial infarction.
    Yasuda S; Miyazaki S; Kinoshita H; Nagaya N; Kanda M; Goto Y; Nonogi H
    Clin Sci (Lond); 2007 Jan; 112(1):43-9. PubMed ID: 16939410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum soluble CD40L level and its application in coronary heart disease].
    Li J; Peng DQ; Zhao SP
    Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):611-4. PubMed ID: 15804073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary stenting is associated with an acute increase in plasma myeloperoxidase in stable angina patients but not in patients with acute myocardial infarction.
    Aminian A; Boudjeltia KZ; Babar S; Van Antwerpen P; Lefebvre P; Crasset V; Leone A; Ducobu J; Friart A; Vanhaeverbeek M
    Eur J Intern Med; 2009 Sep; 20(5):527-32. PubMed ID: 19712859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in inflammatory markers in acute myocardial infarction: a longitudinal study.
    Napoleão P; Santos MC; Selas M; Viegas-Crespo AM; Pinheiro T; Ferreira RC
    Rev Port Cardiol; 2007 Dec; 26(12):1357-63. PubMed ID: 18338665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of increased expression of CD40L in patients with acute coronary syndromes.
    Yan J; Wu Z; Huang Z; Li L; Zhong R; Kong X
    Chin Med J (Engl); 2002 Apr; 115(4):491-3. PubMed ID: 12133281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between upregulation of CD40 system and restenosis in patients after percutaneous coronary intervention.
    Yan JC; Ding S; Liang Y; Ma GS; Zhu J; Feng Y; Luo D
    Acta Pharmacol Sin; 2007 Mar; 28(3):339-43. PubMed ID: 17302995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation of the Inflammatory Reaction following PCI for Acute Myocardial Infarction.
    Aström-Olsson K; Hedström E; Hultén LM; Wiklund O; Arheden H; Ohlin AK; Gottsäter A; Ohlin H
    J Invasive Cardiol; 2007 Nov; 19(11):452-6. PubMed ID: 17986718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble CD40L levels are regulated by the -3459 A>G polymorphism and predict myocardial infarction and the efficacy of antithrombotic treatment in non-ST elevation acute coronary syndrome.
    Mälarstig A; Lindahl B; Wallentin L; Siegbahn A
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1667-73. PubMed ID: 16627810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of matrix metalloproteinases and interleukin-6 in the culprit coronary artery of myocardial infarction.
    Suzuki H; Kusuyama T; Sato R; Yokota Y; Tsunoda F; Sato T; Shoji M; Iso Y; Koba S; Katagiri T
    Eur J Clin Invest; 2008 Mar; 38(3):166-73. PubMed ID: 18257779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
    Orn S; Manhenke C; Squire IB; Ng L; Anand I; Dickstein K
    J Card Fail; 2007 Dec; 13(10):843-9. PubMed ID: 18068618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum brain-derived neurotrophic factor and platelet activation evaluated by soluble P-selectin and soluble CD-40-ligand in patients with acute myocardial infarction.
    Lorgis L; Amoureux S; de Maistre E; Sicard P; Bejot Y; Zeller M; Vergely C; Sequeira-Le Grand A; Lagrost AC; Berchoud J; Cottin Y; Rochette L
    Fundam Clin Pharmacol; 2010 Aug; 24(4):525-30. PubMed ID: 19909348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein.
    Maier W; Altwegg LA; Corti R; Gay S; Hersberger M; Maly FE; Sütsch G; Roffi M; Neidhart M; Eberli FR; Tanner FC; Gobbi S; von Eckardstein A; Lüscher TF
    Circulation; 2005 Mar; 111(11):1355-61. PubMed ID: 15753219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention.
    Hassan AK; Bergheanu SC; Hasan-Ali H; Liem SS; van der Laarse A; Wolterbeek R; Atsma DE; Schalij MJ; Jukema JW
    Am J Cardiol; 2009 Mar; 103(6):779-84. PubMed ID: 19268731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.